Introduction {#Sec1}
============

*Melia azedarach* Linn. (Meliaceae) are widely distributed in southern districts of the Yellow River in China. The fruits and bark are commonly used as famous Traditional Chinese Medicine for acesodyne and disinsection \[[@CR1]\]. This species has been reported to contain triterpenoids, steroids, limonoids, flavonoid glycosides, and simple phenolics \[[@CR2]\], which have been found to possess some benefic pharmacological effects, including analgesic, anticancer, antiviral, antimalarial, antibacterial, and antifeedant activities \[[@CR3], [@CR4]\].

As a well known natural pesticide, azadirachtin has attracted much attention \[[@CR5]\]. Previous investigations of the bark and roots of *M. azedarach* have shown that it is a rich source of meliacarpinin type limonoids \[[@CR6]--[@CR10]\]. Until now, few chemical studies have analyzed its leaves and twigs, which prompted us to conduct this project. We identified three new compounds: a meliacarpinin type limonoid (**1**), an apotirucallane derivative (**2**), and a sterol (**3**), together with six known compounds (**4**--**9**) (Fig. [1](#Fig1){ref-type="fig"}). Herein, we report the details of the isolation, structural elucidation of compounds **1**--**3**.Fig. 1The structures of compounds **1**--**9**

Results and Discussion {#Sec2}
======================

The air-dried powder of *M. azedarach* leaves and twigs was extracted with MeOH (30 L × 3) at room temperature three times to give the residue, which was then partitioned between CHCl~3~ and water to get the CHCl~3~ soluble fraction. Then, three new constituents together with six known compounds were acquired by a series of chromatographic methods. Herein, we described the isolation and structural elucidation of these new compounds.

Compound **1** was isolated as an amorphous powder. The molecular formula was determined as C~37~H~50~O~15~ from the HREIMS ion peak at *m*/*z* 734.3159 \[M\]^+^ (calcd for 734.3150). Its IR spectrum showed the presence of hydroxyl (3456 cm^−1^) and carbonyl (1739 cm^−1^) groups. The 1D NMR data (Table [1](#Tab1){ref-type="table"}) of **1** displayed characteristic signals of meliacarpinin skeleton with three methyls (*δ*~H~ 1.75, s, 3H; *δ*~H~ 0.95, s, 3H; *δ*~H~ 1.66, s, 3H), two methoxyls (*δ*~H~ 3.29, s, 3H; *δ*~H~ 3.79, s, 3H), two acetyls (*δ*~H~ 1.90, s, 3H; *δ*~H~ 2.30, s, 3H), one 2-methylbutyryl (*δ*~H~ 2.59, m; *δ*~H~ 1.27, d, *J* = 7.1 Hz; *δ*~H~ 1.53, m; *δ*~H~ 2.02, m; *δ*~H~ 0.99, t, *J* = 7.4 Hz) and one hydroxyl (*δ*~H~ 4.34, s, 1H) groups, which had a close resemblance to 3-tigloyl-1,20-diacetyl-11-methoxymeliacarpinin \[[@CR8]\], except for the presence of one 2-methylbutyryl moiety in **1** instead of the tigloyl group at C-3 in. 3-tigloyl-1,20-acetyl-11-methoxymeliacarpinin. Observed the HMBC correlations (Fig. [2](#Fig2){ref-type="fig"}) of of H-2′ (*δ*~H~ 2.59, m), H-3′ (*δ*~H~ 1.27, d, *J* = 7.1 Hz), H-4′a (*δ*~H~ 1.53, m) with C-1′ (*δ*~C~ 176.1), and ^1^H-^1^H COSY correlations of H-3′/H-2′/H-4′/H-5′ (*δ*~H~, 0.99, t, *J* = 7.4 Hz) confirmed above deduction. The linkage of 2-methylbutyryl moiety to C-3 was determined by the HMBC correlations from H-3 (*δ*~H~ 4.96, br. t, *J* = 2.7 Hz) to C-1 (*δ*~C~ 71.2), C-5 (*δ*~C~ 35.2), and C-1′.Table 1^1^H NMR and ^13^C NMR spectroscopic data of **1** and **2**Pos**1** ^a^Pos**2** ^b^*δ*~H~ (*J*, Hz)*δ* ~C~*δ*~H~ (*J*, Hz)*δ* ~C~14.26 (d, 9.3)71.2 d1a1.27 (m)35.0 t2a2.27 (m)28.4 t1b1.43 (m)2b2.34 (m)2a1.60 (m)23.9 t34.96 (br. t, 2.7)71.6 d2b1.99 (m)442.9 s34.65 (t, 2.7)80.1 d53.33 (d, 12.7)35.2 d437.7 s64.12 (br. d, 9.2)72.1 d52.09 (m)43.5 d74.53 (br. d, 5.7)84.0 d6a1.71 (m)25.6 t852.3 s6b1.83 (m)93.84 (s)48.5 d73.95 (s-like)74.1 d1050.1 s845.3 s11107.7 s92.12 (m)43.7 d12170.5 s1038.9 s1394.1 s11a1.53 (m)17.9 t1493.2 s11b1.71 (m)154.34 (overlap)82.3 d12a1.55 (m)36.3 t16a1.93 (m)29.4 t12b1.93 (m)16b2.26 (m)1347.9 s173.18 (d, 5.9)48.7 d14162.7 s181.75 (s)26.2 q155.49 (d, 2.4)121.1 d19a4.12 (br. d, 9.2)70.7 t16a2.12 (m)35.9 t19b5.01 (overlap)16b2.31 (ddd, 15.1, 7.3, 3.6)2092.2 s172.04 (m)53.8 d215.98 (s)106.7 d181.03 (s)19.6 q225.59 (d, 3.0)106.2 d190.96 (s)16.1 q236.65 (d, 3.0)147.6 d201.94 (m)37.4 d28a3.68 (d, 3.0)76.7 t21a3.46 (dd, 11.5, 2.6)71.3 t28b3.70 (br. s)21b4.02 (d, 11.5)290.95 (s)18.2 q22a2.01 (m)37.6 t301.66 (s)18.5 q22b1.56 (m)14-OH4.34 (s)233.83 (ddd, 10.8, 9.0, 4.6)65.7 d11-OMe3.29 (s)52.4 q242.88 (d, 9.0)87.8 d12-OMe3.79 (s)53.0 q2574.5 s1-CH~3~[C]{.ul}O170.5 s261.22 (s)24.6 q20-CH~3~[C]{.ul}O171.2 s271.23 (s)28.0 q1-[C]{.ul}H~3~COO1.90 (s)20.6 q280.85 (s)28.4 q20-[C]{.ul}H~3~COO2.30 (s)21.5 q290.95 (s)22.4 q1′176.1 s301.11 (s)28.7 q2′2.59 (m)41.0 d1′169.3 s3′1.27 (d, 7.1)16.7 q2′130.3 s4′a1.53 (m)26.3 t3′6.92 (qq, 7.1, 1.4)138.6 d4′b2.02 (m)4′1.81 (dd, 7.1, 1.1)14.6 q5′0.99 (t, 7.4)11.8 q5′1.85 (s-like)12.4 q^a^Recorded in C~5~D~5~N; ^1^H and ^13^C NMR recorded at 500, 125 MHz^b^Recorded in CD~3~OD; ^1^H and ^13^C NMR recorded at 600, 150 MHzFig. 2Selected ^1^H-^1^H COSY (![](13659_2014_19_Article_Figa_HTML.gif){#d29e1431}) and HMBC (![](13659_2014_19_Article_Figb_HTML.gif){#d29e1434}) correlations of **1**--**3**

The absolute configuration of C-2′ was determined as *S,* supported by the \[*α*\]~D~^15^ value at +16.3 of (*S*)-2-methylbutyric acid derived from **1** by alkaline hydrolysis (\[*α*\]~D~^22^ −14.3 for (*R*)-2-methylbutyric acid and \[*α*\]~D~^25^ +19.3 for (*S*)-2-methylbutyric acid) \[[@CR11], [@CR12]\]. The ROESY correlation (Fig. [3](#Fig3){ref-type="fig"}) between H-3 and H-6*β* (*δ*~H~ 4.12, br. d, *J* = 9.2 Hz) indicated that the 2-methylbutyryloxy was *α*-oriented. Other relative configuration of **1** were identical with those of 3-tigloyl-1,20-acetyl-11-methoxyneliacarpinin on the basis of ROESY spectrum. Therefore, chemical structure of **1** was deduced as 3*α*-(2-methylbutyryl)- 1,20-diacetyl-11-methoxymeliacarpinin.Fig. 3Selected ROESY (![](13659_2014_19_Article_Figc_HTML.gif){#d29e1531}) correlations of **1**--**3**

Compound **2** was obtained as an amorphous powder. Based on the positive HREIMS (*m*/*z* 572.4083, calcd for 572.4077), the molecular formula was defined as C~35~H~56~O~6~. The ^1^H NMR, ^13^C-DEPT (Table [1](#Tab1){ref-type="table"}) spectra showed the presence of nine methyls (two of which belonged to a tigloyl), eight methylenes (one oxygenated), eight methines (four oxygenated), one trisubstituted double bond, and four quaternary carbon. These data suggested that **2** was the apo-tirucallol (euphol) skeleton \[[@CR13]\]. Comparison of NMR data of **2** with those of compound **5** (CAS NO: 1002345-41-6) revealed that they were similar \[[@CR14]\], except that a senecioyl ester side chain at C-3 in compound **5** was replaced by a tigloyl group (*δ*~C~ 169.3 C-1′, 130.3 C-2′, 138.6 C-3′, 14.6 C-4′, and 12.4 C-5′) in **2** \[[@CR8]\], which was confirmed by the HMBC correlations (Fig. [2](#Fig2){ref-type="fig"}) of H-3 (*δ*~H~ 4.65, t, *J* = 2.7 Hz), H-3′ (*δ*~H~ 6.92, qq, *J* = 7.1, 1.4 Hz), and H-5′ (*δ*~H~ 1.85, s-like) with C-1′, and of H-4′ (*δ*~H~ 1.81, dd, *J* = 7.1, 1.1 Hz) with C-2′, together with the ^1^H-^1^H COSY correlations of H-3′/H-4′.

The ROESY correlation (Fig. [3](#Fig3){ref-type="fig"}) between H-3 and Me-19*β* suggested that the tigloyl group at C-3 was *α*-oriented. The coupling constant between H-23 and H-24 (*J* = 9.0 Hz) suggested their anti-periplanar relation \[[@CR14]\], and combination with the ROESY correlations of H-17/H-23, H-17/H-19*β*, H-20/Me-18*α* and H-24/Me-18*α* revealed that the configuration of C-23 and C-24 were both *R*\*. Thus, the structure of **2** was established as 3*α*-tigloyl-17*α*-20*S*-21,24-epoxy-apotirucall-14-en-7*α*,23*α*,25-triol.

Compound **3** was isolated as an amorphous powder. The HREIMS of **3** gave a \[M\]^+^ ion peak at *m*/*z* 320.1985 (calcd for 320.1988), consistent with the molecular formula of C~19~H~28~O~4~. Detailed analysis of its ^1^H and ^13^C-DEPT (Table [2](#Tab2){ref-type="table"}) and 2D NMR data indicated that **3** and 2*α*,3*α*-dihydroxyandrostan-16-one 2*β*,19-hemiketal \[[@CR15]\] had the same planar structure. The only difference between them was the configuration of substituent group at C-3. Comparison its ^1^H NMR data with that of *epi*-isomer showed that the coupling constants of H-3 (*δ*~H~ 4.11, dd, *J* = 10.3, 6.0 Hz) and the chemical shifts for H-1*α* (*δ*~H~ 1.38, d, *J* = 11.3 Hz) and H-1*β* (*δ*~H~ 2.54, d, *J* = 11.3 Hz) were obviously different from those of 2*α*,3*α*-dihydroxyandrostan-16-one 2*β*,19-hemiketa. But the aforementioned data was familiar with 2*α*,3*β*-dihydroxypregnan-16-one 2*β*,19-hemiketal \[[@CR10]\], which implied that the H-3 of **3** was *α*-oriented. This conclusion further confirmed by the cross peak between H-3 and H-5 (*δ*~H~ 1.38, overlap) in the ROESY spectrum (Fig. [3](#Fig3){ref-type="fig"}). So the hydroxyl group at C-3 was *β*-configuration. Consequently, the chemical structure of **3** was elucidated as 2*α*,3*β*-dihydroxyandrostan-16-one 2*β*,19-hemiketal.Table 2^1^H NMR and ^13^C NMR spectroscopic data of **3**Pos*δ*~H~ (*J*, Hz)*δ* ~C~Pos*δ*~H~ (*J*, Hz)*δ* ~C~1a1.38 (d, 11.3)44.3 t11a1.34 (m)21.5 t1b2.54 (d, 11.3)11b1.58 (m)2106.3 s12a1.20 (m)38.2 t34.11 (dd, 10.3, 6.0)74.7 d12b1.59 (m)4a1.73 (m)39.1 t1339.2 s4b2.19 (m)141.24 (m)51.7 d51.38 (overlap)43.8 d15a1.84 (m)39.7 t6a1.16 (m)29.8 t15b2.14 (dd, 17.9, 7.5)6b1.46 (m)16217.5 s7a0.79 (overlap)32.3 t17a1.93 (d, 16.6)56.2 t7b1.37 (overlap)17b2.06 (d, 16.6)80.80 (overlap)36.8 d180.64 (s)18.1 q91.05 (m)46.4 d19a3.86 (d, 8.1)67.6 t1048.2 s19b4.08 (d, 8.1)Recorded in C~5~D~5~N; ^1^H and ^13^C NMR recorded at 600, 150 MHz

Six known constituents: 1-cinnamoyl-3-acetyl-11-methoxymeliacarpinin (**4**) \[[@CR8]\], 3-tigloyl-1,20-diacetyl-11-methoxymeliacarpinin (**5**) \[[@CR8]\], 3*S*,23*R*,25-trihydroxytirucall-7-en-24-one (**6**) \[[@CR16]\], and 2*α*,3*α*,16*β*-trihydroxy-5*α*-pregnane 20*R*-methacrylate (**7**) \[[@CR17]\], 6-de(acetyloxy)-7-deacetylchisocheton compound E (**8**) \[[@CR18]\], Toonapubesin C (**9**) \[[@CR19]\], were identified by comparison of their spectroscopic data with those reported in the literature.

Experimental {#Sec3}
============

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotations were measured with a Horiba SEPA-300 polarimeter. UV spectra were detected on a Shimadzu UV-2401A spectrophotometer. IR spectra were measured on a Bruker Tensor-27 infrared spectrophotometer with KBr pellets. ESIMS analysis were recorded on an API QSTAR Pulsar I spectrometer. EIMS and HREIMS were performed on a Waters Autospec Premier P776 mass spectrometer. 1D and 2D NMR spectra were recorded on Bruker DRX-500 and Bruker Avance III-600 spectrometers with TMS as internal standard. Semi-preparative HPLC studies were carried out on an Agilent 1100 liquid chromatograph with a Zorbax SB-C18 (9.4 mm × 25 cm) column. Column chromatography was performed with silica gel (200--300 mesh, Qingdao Marine Chemical, Inc.), Sephadex LH-20 (20--150 μm, Pharmacia), and Lichroprep RP-18 (40**--**63 μm, Merck). Fractions were monitored by TLC, and spots were visualized by heating the silica gel plates sprayed with 10 % H~2~SO~4~ in EtOH.

Plant Material {#Sec5}
--------------

The leaves and twigs of *M. azedarach* were collected from Kunming, Yunnan Province, China. A voucher sample (NO: 2011-05-07) has been deposited in the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences.

Extraction and Isolation {#Sec6}
------------------------

The air-dried and powdered leaves and twigs of *M. azedarach* (10 kg) were extracted with MeOH (30 L × 3) at room temperature. Evaporation of the solvent under reduced pressure provide a dark residue (700 g), which was suspended in water and then partitioned with CHCl~3~ and *n*-BuOH, successively, to yield CHCl~3~ fraction (120 g), *n*-BuOH fraction (156 g). The CHCl~3~ extract was chromatographed by silica gel column eluted with CHCl~3~-MeOH as a gradient (100:1, 50:1, 20:1, 5:1) to afford four fractions. The CHCl~3~-MeOH (100:1) portion was evaporated to obtain a residue (20 g), which was subjected to silica gel chromatograph column with petroleum ether-EtOAc (10:1, 6:1, 3:1, 1:1) as elution, to give four fractions (A, B, C, and D). Fraction B (5 g) was further subjected to RP-18 chromatograph column, eluting with MeOH-H~2~O (40:60, 60:40, 80:20, and 100:0) to afford five fractions: B1--B5. Fraction B4 was then purified by HPLC (70 % CH~3~CN aq.; 2.0 mL/min; 210 nm; Zorbax SB-C18, 9.4 mm × 25 cm) to give compounds **1** (4 mg), **4** (2 mg) and **5** (3 mg). In the same way, **2** (4 mg), **6** (5 mg) and **9** (7 mg) were islated from fraction B3. Fraction B2 was subjected to silica gel chromatograph column with petroleum ether-EtOAc (8:1, 5:1, 3:1, 1:1, and 0:1) as elution, to give five subfractions (E, F, G, and H). Subfraction F was further separated and purified by silica gel chromatography column with CHCl~3~-Me~2~CO (50:1, 20:1, 5:1, and 1:1) as elution, get four subfraction: F1--F4, subfraction F2 was successively subjected to Sephadex LH-20 (MeOH) and HPLC (80 % CH~3~CN aq.; 2.0 mL/min; 210 nm; Zorbax SB-C18, 9.4 mm × 25 cm), and compounds **3** (1.5 mg), **7** (3 mg) and **8** (6 mg) were obtained.

3*α*-(2-Methylbutyryl)-1,20-diacetyl-11-methoxymeliacarpinin (**1**) {#Sec7}
--------------------------------------------------------------------

Amorphous powder; \[*α*\]~D~^17^ --17.8 (*c* 0.08, MeOH); UV (MeOH) λ~max~ (log *ε*) 208 (4.09) nm; IR (KBr) ν~max~ 3456, 2953, 1739, 1706, 1618, 1438, 1376, 1252, 1160, 1131, 1061, and 949 cm^−1^; ^1^H NMR (500 MHz, C~5~D~5~N) and ^13^C DEPT (125 MHz, C~5~D~5~N) data, see Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}; positive ESIMS *m*/*z* 757 \[M+Na\]^+^; positive HREIMS *m*/*z* 734.3159 (calcd for C~37~H~50~O~15~ \[M\]^+^, 734.3150).

3*α*-Tigloyl-17*α*-20*S*-21,24-epoxy-apotirucall-14-en-7*α*,23*α*,25-triol (**2**) {#Sec8}
----------------------------------------------------------------------------------

Amorphous powder; \[*α*\]~D~^17^ --28.9 (*c* 0.20, MeOH); UV (MeOH) λ~max~ (log *ε*) 204 (3.80) nm; IR (KBr) ν~max~ 3441, 2927, 2855, 1631, 1452, 1384, 1268, 1075 and 578 cm^−1^; ^1^H NMR (600 MHz, CD~3~OD) and ^13^C DEPT (150 MHz, CD~3~OD) data, see Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}; positive ESIMS *m*/*z* 595 \[M+Na\]^+^; positive HREIMS *m*/*z* 572.4083 (calcd for C~35~H~56~O~6~ \[M\]^+^, 572.4077).

2*α*,3*β*-Dihydroxyandrostan-16-one 2*β*,19-hemiketal (**3**) {#Sec9}
-------------------------------------------------------------

Amorphous powder; \[*α*\]~D~^17^ --48.0 (*c* 0.30, MeOH); UV (MeOH) λ~max~ (log *ε*) 202 (3.56), 219 (3.51) nm; IR (KBr) ν~max~ 3464, 2924, 2874, 1720, 1447, 1295, 1187, 1130, 1044, and 993 cm^−1^; ^1^H NMR (600 MHz, C~5~D~5~N) and ^13^C DEPT (150 MHz, C~5~D~5~N) data, see Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}; positive ESIMS *m*/*z* 343 \[M+Na\]^+^; positive HREIMS *m*/*z* 320.1985 (calcd for C~20~H~28~O~5~ \[M\]^+^, 320.1988).
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